exhibition and floor plan scientific program - Malmö Kongressbyrå AB
exhibition and floor plan scientific program - Malmö Kongressbyrå AB
exhibition and floor plan scientific program - Malmö Kongressbyrå AB
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
EXHIBITION AND FLOOR PLAN<br />
16<br />
Posters<br />
Coffee<br />
Posters<br />
Stairs<br />
1<br />
1. Roche <strong>AB</strong><br />
2. Ev3 Nordic <strong>AB</strong>/Covidien<br />
3. Toshiba Medical Systems Sweden<br />
4. Children’s Mission<br />
5. Cook Medical<br />
6. Ellipse/Scanex<br />
7. Terumo<br />
8. Swedish Klippel-Trenaunay Syndrome Soc.<br />
9. medi<br />
2<br />
Entrance<br />
3<br />
Lecture Hall<br />
4 5 6<br />
Stairs Stairs<br />
Posters<br />
Lunch/Dinner<br />
10. Pierre Fabre Dermatologie<br />
7<br />
Entrance<br />
8<br />
9<br />
10<br />
Stairs<br />
Coffee<br />
Lunch<br />
Lunch<br />
Time SATURDAY JUNE 16 (BASIC COURSE)<br />
07.00 Registration at <strong>Malmö</strong> Opera<br />
08.30 Welcome remarks<br />
Agneta Troilius<br />
08.40 Terminology <strong>and</strong> classification<br />
Arin Greene<br />
09.10 Hemangiomas - natural course <strong>and</strong> treatment<br />
Christine Léauté-Labrèze<br />
09.40 Surgery on Hemangiomas<br />
Carolin Freccero<br />
10.00 Fruit <strong>and</strong> coffee break<br />
SCIENTIFIC PROGRAM<br />
10.45 Venous Malformations - natural course <strong>and</strong> surgical treatment<br />
Laurence Boon<br />
11.15 Venous Malformations - diagnostic <strong>and</strong> interventional radiology<br />
Pär Gerwins<br />
11.45 Diagnostic <strong>and</strong> interventional radiology in Lymphatic<br />
Malformations<br />
Alej<strong>and</strong>ro Berenstein<br />
12.15 Lymphatic Malformations - investigations, challenges <strong>and</strong><br />
surgical solutions<br />
Milton Waner<br />
12.45 Lunch 12:45-14:45<br />
Histopathology of Vascular<br />
Anomalies including important<br />
markers<br />
Paula North<br />
14.00 IPL treatment of Vascular Anomalies<br />
Michael L<strong>and</strong>thaler<br />
14.30 Laser treatment of Vascular Anomalies<br />
Agneta Troilius<br />
(Stora Konferensrummet<br />
Entrance: Verkstaden)<br />
Bring the lunch<br />
15.00 AV-malformations - natural course <strong>and</strong> interventional radiology<br />
Susanne Frevert<br />
17
SCIENTIFIC PROGRAM<br />
18<br />
Time SATURDAY JUNE 16<br />
15.30 Stretch <strong>and</strong> coffee break<br />
16.15 Histopathology of Vascular Anomalies including important markers<br />
Paula North<br />
16.45-17.15 Basic knowledge regarding genetics in Vascular Anomalies<br />
Miikka Vikkula<br />
18.00 Welcome Reception at <strong>Malmö</strong> Opera (Preregistration m<strong>and</strong>atory)<br />
Time SUNDAY JUNE 17<br />
07.00 Registration at <strong>Malmö</strong> Opera<br />
08.00 Opening ceremony & Welcome<br />
08.15 Remembering Odile Enjolras<br />
John Mulliken, Michel Wassef<br />
08.25 Keynote speaker<br />
”Mechanisms of growth <strong>and</strong> involution of infantile hemangioma”<br />
08.55-10.17 Session I<br />
Bjorn R. Olsen, MD, PhD<br />
Hersey Professor of Cell Biology, Harvard Medical School,<br />
Professor of Developmental Biology <strong>and</strong> Dean for Research,<br />
Harvard School of Dental Medicine<br />
Chair: Julie Powell, Paul Rieu<br />
08.55 The Natural History of the Hepatic Rapidly Involuting Congenital<br />
Hemangioma<br />
R Dawn Fevurly, Ann M Kulungowski, Emily R Christison-Lagay, Victor<br />
M Johnson, David Zurakowski, Ahmad I Alomari <strong>and</strong> Steven J Fishman<br />
09.05 A Prospective study of Infantile Hemangiomas in Twins<br />
M. Fern<strong>and</strong>a Greco, MD, Ilona J. Frieden, MD, Beth A. Drolet, MD,<br />
M. Rosa Cordisco, MD <strong>and</strong> Hemangioma Investigator Group<br />
09.13 Three-dimensional photograph registration in infantile hemangioma<br />
follow-up<br />
Denise Hermans, Thomas Maal, Stefaan Bergé <strong>and</strong><br />
Carine van der Vleuten<br />
09.21 Early Growth of Infantile Hemangiomas: What Parents’<br />
Photographs Tell Us<br />
Megha Tollefson <strong>and</strong> Ilona Frieden<br />
09.31 Gastrointestinal Infantile Hemangiomas: A Retrospective Analysis<br />
Ines Wu, Marilyn Liang, Victor Fox, Ahmad Alomari, John Mulliken <strong>and</strong><br />
Steven Fishman<br />
SCIENTIFIC PROGRAM<br />
09.39 Increased risk for speech delay <strong>and</strong> dysphagia in patients with<br />
PHACE syndrome.<br />
Kari Martin, Joan Arvedson, Beth Drolet, Dawn Siegel <strong>and</strong><br />
Robert Chun<br />
09.49 Vincristine-aspirin-ticlopidine (vat) therapy: no mortality in vascular<br />
tumors associated with kasabach-merritt phenomenon in the last<br />
15 years<br />
Israel Fern<strong>and</strong>ez-Pineda, Juan Carlos Lopez-Gutierrez,<br />
Gloria Chocarro, Jose Bernabeu-Wittel <strong>and</strong> Gema Ramirez<br />
09.57 Multidisciplinary consensus-driven treatment protocols for KHE<br />
<strong>and</strong> uniform diagnostic criteria for MLT<br />
Yvonne Chiu, Denise Adams, Maria Garzon, Michael Kelly, Kelly Duffy<br />
<strong>and</strong> Beth Drolet<br />
10.07 Sirolimus for the treatment of Kaposiform Hemangioendotheliomas/Tufted<br />
Angiomas<br />
Denise M. Adams, Adrienne M. Hammill, Mary Sue Wentzel,<br />
Christine Minges, Rebecca Turner, Kristina Kruskamp, Carol Chute,<br />
Manish Patel, Carl Merrow, Belinda Dickie, Roshni Dasgupta,<br />
Ravi G. Elluru <strong>and</strong> Richard G. Azizkhan<br />
10.17 Fruit & coffee break <strong>and</strong> Poster session<br />
11.00-12.28 Session II<br />
Chair: Beth Drolet, Michel Wassef<br />
11.00 HEMANGIOL STUDY: the first world wide dose effect study<br />
concerning propranolol in infantile hemangiomas<br />
Christine Léauté-Labrèze, Caroline Morgan <strong>and</strong> Jean-Jacques Voisard<br />
11.10 Cardiovascular <strong>and</strong> Blood Glucose Parameters in Infants initiated<br />
on Propranolol for Treatment of Symptomatic Hemangiomas<br />
Katherine Puttgen, Jeremy Schneider, E. A. Greene, P. C. Guzzetta,<br />
A. K. Oh, Shetarra Walker, Bernard Cohen, Emily Boss <strong>and</strong><br />
Nancy Bauman<br />
11.20 Exp<strong>and</strong>ing the therapeutic repertoire of infantile hemangiomas:<br />
Cohort blinded study of oral nadolol compared with propranolol<br />
Elena Pope, Ajith Chakkittak<strong>and</strong>iyil, Irene Lara-Corrales, Ellen Maki,<br />
Bing Wu, Miriam Weinstein <strong>and</strong> Sylvain Baruchel<br />
11.30 Efficacy of Acebutolol for the Treatment of Infantile Hemangiomas<br />
Cameron Francis, Ashley Dunn, Ashley Karatsonyi, Sheila Nazarian-<br />
Mobin, Yvonne Gutierrez, Dean Anselmo <strong>and</strong> Andre Panossian<br />
11.38 Topical betablockers for infantile hemangiomas are effective but<br />
systemically absorbed<br />
Lisa Weibel, Helene Sophie Scheer, Marjam Barysch, Ingo Königs,<br />
Daniel Müller, Clemens Schiestl <strong>and</strong> Katharina Rentsch<br />
11.48 Timolol maleate for infantile haemangiomas: preliminary results of<br />
an open label, prospective study<br />
Kristina Semkova <strong>and</strong> Jana Kaz<strong>and</strong>jieva<br />
19
SCIENTIFIC PROGRAM<br />
20<br />
11.58 Propranolol suppresses angiogenesis through inhibiting the PI3K/<br />
Akt <strong>and</strong> ERK signaling pathways in endothelial cells<br />
Jun Jia, Hai-Xiao Zou, Gang Chen <strong>and</strong> Yi-Fang Zhao<br />
12.08 Propranolol causes functional changes in hemangioma stem cells<br />
<strong>and</strong> hemangioma endothelial cells<br />
Alvin Wong, Krista Hardy, Alex Kitajewski, Carrie J. Shawber,<br />
Jan K. Kitajewski <strong>and</strong> June K. Wu<br />
12.18 Treatment of Infantile Haemangioma with Captopril<br />
12.28 Lunch<br />
13.30-14.28 Session III<br />
Swee Tan, Tinte Itinteang, Darren Day, Clare O’Donnell, Jon Mathy <strong>and</strong><br />
Philip Leadbitter<br />
Chair: Gresham Richter, Francine Blei<br />
13.30 Genome-Wide Association Study (GWAS) of Infantile Hemangiomas<br />
(IH): Functional Significance of C<strong>and</strong>idate Genes<br />
Eun-Kyung M. Kwon, Dawn H. Siegel, Paula E. North, Yvonne E. Chiu,<br />
Elizabeth Worthey, Ulrich Broeckel <strong>and</strong> Beth Ann Drolet<br />
13.38 p16INK4a-mediated Endothelial Cellular (EC) Senescence is a<br />
Fundamental Mechanism of Spontaneous Involution in Infantile<br />
Hemangioma (IH)<br />
Qiuhui Yang, Valerie Salato, Kathrin Scherer, Hanae Onodera,<br />
Isabel DeAos, Barbara Wimpee, Milton Waner, Martin Mihm,<br />
Julie Tetzlaff <strong>and</strong> Paula North<br />
13.48 Notch3 modulates cellular differentiation of hemangioma stem<br />
cells: A potential regulator of hemangioma stem cell fate<br />
Krista Hardy, Alvin Wong, Carrie J. Shawber, Alex Kitajewski,<br />
Jan K. Kitajewski <strong>and</strong> June K. Wu<br />
13.58 M2-polarized macrophages in infantile hemangiomas: correlation<br />
with promoted angiogenesis<br />
Gang Chen, Feng-Qin Wang, Jun Jia, Zhi-Jun Sun <strong>and</strong> Yi-Fang Zhao<br />
14.08 Pyogenic Granuloma, an Impaired Wound Healing Process Driven<br />
by VEGFR3 <strong>and</strong> the NO Pathway<br />
Catherine Godfraind, Monica L. Calicchio <strong>and</strong> Harry P.W. Kozakewich<br />
14.18 WT1 expression in the endothelial cells of vascular anomalies: A<br />
marker of vessel type <strong>and</strong> not of the tumor / malformation nature of<br />
the lesion, with special expression in IH <strong>and</strong> placenta.<br />
14.28 Coffee break<br />
Audrey Mansuet-Lupo, Elisabeth Sauvaget, Michel Borsik, Benoit<br />
Faucon, Didier Salvan, Annouk Bisdorff-Bresson <strong>and</strong> Michel Wassef<br />
14.55 Session IV<br />
Chair: Ilona Frieden, Alex Barnacle<br />
14.55 Dramatic efficacy of systemic steroids for the treatment of an<br />
aggressive orbital IH<br />
NOTES<br />
SCIENTIFIC PROGRAM<br />
Olivia Boccara, Valérie Dekeuleneer, Francis Brunelle, Sylvie Fraitag,<br />
Dominique Hamel-Teillac, Smail Hadj-Rabia <strong>and</strong> Christine Bodemer<br />
15.10 Retroperitoneal RICH in a newborn baby with extensive arteriovenous<br />
shunting <strong>and</strong> acute heart failure.<br />
Mats Cronqvist, Birgitta Ramgren, Agneta Troilius <strong>and</strong> Pär Gerwins<br />
15.25-17.00 General Assembly<br />
17.00 Traditional Swedish Midsummer celebration at Kulturens Östarp<br />
(Buses leaving outside the Opera. Preregistration m<strong>and</strong>atory)<br />
21
SCIENTIFIC PROGRAM<br />
22<br />
Time MONDAY JUNE 18<br />
08.00-09.30 Session V<br />
Chair: Anthony Penington, Ahmad Alomari<br />
08.00 Exome sequencing of suspected HHT patient reveals a novel<br />
RASA1 frameshift mutation: Clinical <strong>and</strong> diagnostic implications<br />
Whitney Wooderchak-Donahue, Marc Singleton, Mark Y<strong>and</strong>ell,<br />
Jamie McDonald, David Stevenson, Johannes Grimmer <strong>and</strong><br />
Pinar Bayrak-Toydemir<br />
08.10 A xenograft animal Model of Human Arteriovenous Malformation<br />
Fang Hou, Yuemeng Dai, Lisa Buckmiller, Chun-Yang Fan, Ali Saad,<br />
James Suen <strong>and</strong> Gresham Richter<br />
08.20 Topological analysis of vessel structures in AVMs using 3D-CTA<br />
Yuki Hata, Koichi Tomita, Ken Matsuda, Yasuo Sakai, Ko Hosokawa,<br />
Keigo Osuga <strong>and</strong> Shuichiro Uehara<br />
08.30 Angioarchitecture of extracranial arteriovenous malformations:<br />
a vascular casting study<br />
Xiaoxi Lin, Da Chen, Xiaojie Hu, Yunbo Jin, Wei Li, Gang Ma <strong>and</strong><br />
Hui Chen<br />
08.38 Arteriovenous malformations treatment strategies based on<br />
transarterial lung perfusion scintigraphy (TLPS)<br />
Birute Vaisnyte, Donatas Vajauskas, Daiva Nevidomskyte, Nerijus<br />
Misonis, Darius Palionis, Marius Kurminas <strong>and</strong> Mindaugas Mataciunas<br />
08.48 Optimization <strong>and</strong> preclinical testing of new biocompatible <strong>and</strong><br />
adsorbable hydrogel made of chitosan <strong>and</strong> sodium sotradecol<br />
sulfate<br />
Gilles Soulez, Pascal Chabrot, Ahmed Fatimi, Jean-Michel Coutu,<br />
Saoussen Berrahmoune <strong>and</strong> Sophie Lerouge<br />
08.56 Propranolol Therapy for AVMs<br />
James Suen, Brad Hobbs <strong>and</strong> Gresham Richter<br />
09.06 Propranolol as antiangiogenic c<strong>and</strong>idate for the therapy of<br />
Hereditary Haemorragic Telangiectasia<br />
Virginia Albiñana, Lucía Recio-Poveda, Roberto Zarrabeitia,<br />
Carmelo Bernabeu <strong>and</strong> Luisa María Botella<br />
09.14 The HHT2 gene Activin Receptor-Like Kinase 1 (ALK1) is<br />
upregulated upon vascular injury via a transcriptional cooperation<br />
between Krüppel-like factor 6 (KLF6) <strong>and</strong> Sp1<br />
Eva M. Garrido-Martín, Mercé Roquè, Francisco J Blanco,<br />
Laura Novensa, Mirko Tarocchi, Ursula E. Lee, Toru Suzuki,<br />
Scott L. Friedman, Luisa M. Botella <strong>and</strong> Carmelo Bernabeu<br />
09.22 Thalidomide is an Effective Treatment for Arteriovenous<br />
Malformations associated with Pain, Ulceration <strong>and</strong>/or Bleeding<br />
Laurence Boon, Vincent Qin, Liliane Marot, Frank Hammer, Anne<br />
Jeanjean, Philippe Clapuyt, Anne-Christine Bataille <strong>and</strong> Miikka Vikkula<br />
09.30-10.30 Session VI<br />
Chair: Wayne Yakes, Denise Adams<br />
09.35 Severe Pulmonary Embolic Complications Of Ethanol<br />
Embolotherapy Of Vascular Anomalies<br />
Robert Vogelzang<br />
09.45 Sirolimus (Rapamune) - turning wrong into right?<br />
Henrik Berlin, Cecilia Andersson <strong>and</strong> Carolin Freccero<br />
SCIENTIFIC PROGRAM<br />
10.00 AVM with multiple feeders in the left thigh treated with embolization<br />
of the superficial & deep femoral veins<br />
Auh Whan Park, Alan Matsumoto, John Angle, Wael Saad,<br />
Saher Sabri, Kenneth Cherry <strong>and</strong> Ulku Turba<br />
10.15 High Flow AVM of Pelvis with Congestive Cardiac Failure,<br />
Rectal Bleeding, <strong>and</strong> Limb Ischemia<br />
Martin Simons <strong>and</strong> Kongteng Tan<br />
10.30 Fruit & coffee break <strong>and</strong> Poster session<br />
11.00-13.17 Session VII<br />
Chair: Patricia Burrow, Peter Berlien<br />
11.00 The Natural History of Soft Tissue Hypertrophy, Bony Hypertrophy,<br />
<strong>and</strong> Nodule Formation in Patients with Untreated Head <strong>and</strong> Neck<br />
Capillary Malformation(CM)<br />
Milton Waner, Ho Yun Chung, Teresa O <strong>and</strong> Aaron Fay<br />
11.10 The Cynergy Multiplex Laser for vascular anomalies <strong>and</strong> for other<br />
skin lesions in children<br />
Samira Batul Syed, Maria Gnarra, Katherine Miler, Jane Linward <strong>and</strong><br />
John Harper<br />
11.20 Indocyanine green-augmented diode laser therapy of<br />
port wine stains<br />
Annette Klein, Wolfgang Bäumler <strong>and</strong> Philipp Babilas<br />
11.30 The surgical management of head <strong>and</strong> neck<br />
Capillary Malformations<br />
Milton Waner, Teresa O, Ho Yun Chung, Catharina Poley <strong>and</strong><br />
Aaron Fay<br />
11.40 Capillary Venous Malformation of the Lower Extremities<br />
Lily Uihlein, Marilyn Liang, Ahmad Alomari, Steven Fishman <strong>and</strong><br />
John Mulliken<br />
11.50 Vascular Malformations in Regional Overgrowth Syndromes<br />
Peter Urban, Carsten M. Philipp, Margitta Poetke, Ute Müller,<br />
Hans-Peter Berlien <strong>and</strong> Sigrid Tinschert<br />
23
SCIENTIFIC PROGRAM<br />
24<br />
11.58 Do we need a new classification of the venous anomalies in<br />
Klippel-Trenaunay syndrome? Correlation of the clinical, anatomic<br />
<strong>and</strong> hemodynamic characteristics<br />
Ahmad Alomari <strong>and</strong> Raja Shaikh<br />
12.06 Outcome of Surgical Debulking for Klippel-Trenaunay Syndrome<br />
R Dawn Fevurly, Victor M Johnson <strong>and</strong> Steven J Fishman<br />
12.14 Germline mutations in rasa1 are not found in patients with Klippel-<br />
Trenaunay syndrome or capillary malformation with overgrowth<br />
Nicole Revencu, Laurence Boon, Anne Dompmartin, Paul Rieu,<br />
Josee Dubois, Francesca Forzano, Annet van Hagen, Sarah Halbach,<br />
Alma Kuechler, Augusta Lachmeijer, Jyrki Lähde, Laura Russell,<br />
Kalle Simola <strong>and</strong> Miikka Vikkula<br />
12.22 Clinical Characterization of Fibro-Adipose Vascular Anomaly (FAVA)<br />
Ryan Arnold, Gulraiz Chaudry, Cindy Kerr, Raja Shaikh, Anna Lillis,<br />
Pradeep Govender, Samantha Spencer <strong>and</strong> Ahmad Alomari<br />
12.32 Hematologic profile in CLOVES syndrome <strong>and</strong> risk of<br />
thromboembolism<br />
Erin West, Rebecca Fevurly, Steven Fishman, Ahmad Alomari <strong>and</strong><br />
Cameron Trenor<br />
12.42 Wilms Tumor Screening is Necessary for Children with<br />
CLOVES Syndrome<br />
R Dawn Fevurly, Arin K Greene, Cameron C Trenor III,<br />
Ahmad I Alomari, Denise Adams <strong>and</strong> Steven J Fishman<br />
12.52 Role of Somatic Mutations in the Etiopathogenesis of the<br />
Maffucci Syndrome<br />
Miikka Vikkula, Mustapha Amyere, John B. Mulliken, Anne<br />
Dompmartin, Odile Enjolras, Ilkka Kaitila, Pierre-Louis Docquier,<br />
Catherine Godfraind, Nisha Limaye <strong>and</strong> Laurence M. Boon<br />
13.02-13.17 Unusual pulmonary arteriolar abnormalities in a patient with<br />
Klippel-Trenaunay syndrome<br />
Benoit Ghaye, Laurence M Boon, Frank Hammer <strong>and</strong> Philippe Clapuyt<br />
15.00-17.00 Optional activities in <strong>Malmö</strong> (Preregistration m<strong>and</strong>atory)<br />
19.00 Gala Dinner Dance at <strong>Malmö</strong> Opera (Preregistration m<strong>and</strong>atory)<br />
SCIENTIFIC PROGRAM<br />
Time TUESDAY JUNE 19<br />
07.30-08.30 <strong>Malmö</strong> in the morning: RUN, BIKE or WALK<br />
(Preregistration m<strong>and</strong>atory)<br />
09.10-10.50 Session VIII<br />
Chair: John Mulliken, Carsten Philipp<br />
09.10 Fasudil Decreases Lesion Burden in Murine Models of Cerebral<br />
Cavernous Malformations<br />
Douglas Marchuk, David McDonald, Changbin Chi, Robert Shenkar,<br />
Rebecca Stockton, Feifei Liu, Mark Ginsberg <strong>and</strong> Issam Awad<br />
09.20 Physiopathology of localized intravascular coagulopathy (LIC)<br />
associated to segmental venous malformations (VM): hyperfibrinolysis,<br />
hypocoagulability <strong>and</strong> presence of activated clotting factors<br />
Vittoria Baraldini, Patrizia Della Valle, Francesca Sampietro <strong>and</strong><br />
Arm<strong>and</strong>o D’angelo<br />
09.28 Characterization of Venous Malformations in Blue Rubber Bleb<br />
Nevus Syndrome: The Dominant Lesion.<br />
Anna Lillis, Gulraiz Chaudry, Steven Fishman, Cindy Kerr, Raja Shaikh<br />
<strong>and</strong> Ahmad Alomari<br />
09.36 Identification of the cause of the Blue Rubber Bleb<br />
Nevus Syndrome<br />
Miikka Vikkula, Julie Soblet, Nisha Limaye, Maria R. Cordisco, Anne<br />
Dompmartin, Odile Enjolras, Simon Holden, Alan D. Irvin, Christine<br />
Labrèze, Agustina Lanoel, Paul N. Rieu, Samira Syed, Carine J. Van<br />
der Vleuten, Rosemarie Watson, Steven J. Fishman, John B. Mulliken<br />
<strong>and</strong> Laurence M. Boon<br />
09.46 Single Stage Removal of Localized Head <strong>and</strong> Neck Venous<br />
Malformations with Glue Embolization <strong>and</strong> Surgery<br />
David Tieu, Nghia Vo, Basavaraj Ghodke <strong>and</strong> Jonathan Perkins<br />
09.54 MRI of vascular anomalies: value of diffusion imaging<br />
Josee Dubois, Françoise Rypens, Chantale Lapierre, Julie Powell,<br />
Catherine McCuaig <strong>and</strong> Gilles Soulez<br />
10.04 Bleomycin induces endothelial mesenchymal transition via<br />
activation of Akt/mTOR pathway<br />
Wei Zhang, Jian-Gang Ren <strong>and</strong> Yi-Fang Zhao<br />
10.14 STS sclerotherapy for patients with venous malformation: Clinical<br />
discrepancy between patient-based <strong>and</strong> MRI-based evaluation.<br />
Norimitsu Tanaka, Shuji Nagata, Toshi Abe, Yusuke Uchiyama,<br />
Naofumi Hayabuchi <strong>and</strong> Kensuke Kiyokawa<br />
25
SCIENTIFIC PROGRAM<br />
26<br />
10.22 Prospective r<strong>and</strong>omized evaluation of the treatment efficacy of<br />
ethanol 96% formulated in a gel <strong>and</strong> ethanol 98% solution in<br />
patients with VM<br />
Sally Mitchell, Denis Herbreteau, Deborah Schwengel, Gina Robinson,<br />
Caroline Miklaszewski <strong>and</strong> Patrick Dupuy<br />
10.32 Radiation Exposure during Interventional Radiology procedures for<br />
Vascular Malformations<br />
James Suen, Eren Erdem, Lynn McGuire, Gresham Richter <strong>and</strong><br />
Adewumi Amole<br />
10.42 The 810-nm diode laser. A good wave as an alternative to<br />
superficial VMs’ treatment. A preliminary report.<br />
Gianni Vercellio, Giuseppe Carella, Vittorio Danesino <strong>and</strong><br />
Maria Grazia Bordoni<br />
10.50 Fruit & coffee break <strong>and</strong> Poster session<br />
11.45-13.15 Session IX<br />
Parallel session I (MALMÖ OPERA)<br />
Chair: Agneta Troilius, Michael Drosner<br />
Laser surgery <strong>and</strong> IPL treatment of<br />
Vascular Malformations <strong>and</strong> tumours.<br />
11:45-12.00<br />
Laser treatment of deeper<br />
Vascular Malformations<br />
Agneta Troilius, <strong>Malmö</strong>, Sweden<br />
12.03-12.18<br />
Laser treatment of infantile<br />
hemangiomas<br />
Annette Klein, Regensburg, Germany<br />
12:21-12:36<br />
IPL treatment of Vascular Malformation<br />
<strong>and</strong> tumours with emphasize of<br />
Hemangiomas<br />
Gerd M Kautz, Kontz, Germany<br />
12:39-12:54<br />
IPL treatment of Vascular<br />
Malformations with emphasize of<br />
Capillary Malformations<br />
Michael Drosner, Schwerin, Germany<br />
12.57 -13:12<br />
Intralesional Laser treatment of deeper<br />
Vascular Anomalies<br />
Peter Berlien, Berlin, Germany<br />
Parallel session II (INTIMAN)<br />
Chair: Patricia Burrows, Pär Gerwins<br />
Radiology Case conference<br />
11.45<br />
Sclerotherapy for Lymphatic<br />
Malformations<br />
Speaker TBD<br />
12.15<br />
Endovascular treatment of Venous<br />
Malformations<br />
Speaker TBD<br />
12.45<br />
Embolotherapy of AVM<br />
Speaker TBD<br />
SCIENTIFIC PROGRAM<br />
13.15 Lunch<br />
14.15-15.19 Session X<br />
Chair: Sally Mitchell, TBA<br />
14.15 VEGFR3-driven Lymphangioblast Migration Requires MAPK-ERK<br />
Signaling<br />
R Dawn Fevurly, Domenic Filingeri, Alex<strong>and</strong>er Fye, Sean Hasso,<br />
Steven J Fishman <strong>and</strong> Joanne Chan<br />
14.25 Gene array comparison of lymphatic malformation <strong>and</strong> human<br />
foreskin lymphatic endothelial cells<br />
Tony Penington, Zerina Williams <strong>and</strong> Raminder Dhillon<br />
14.35 A Novel Approach to the Identification of C<strong>and</strong>idate Genes in<br />
Patients with Lymphatic Malformations<br />
Kelly Duffy, Craig Johnson, Jennifer Santoro <strong>and</strong><br />
Ramani Ramch<strong>and</strong>ran<br />
14.45 Abnormal Flow Dynamics in the Central Conducting Lymphatics:<br />
Real-Time Illustration of Potential Etiology.<br />
Ahmad Alomari<br />
14.53 Sclerotherapy as a single-line treatment for orbital<br />
lymphatic malformations<br />
Alex Barnacle, Eva Gajdosova <strong>and</strong> Yassir Abou-Rayyah<br />
15.01 Clinical Applications of Protein Foams in the Treatment of<br />
Vascular Malformations<br />
William Shiels<br />
15.09 Efficacy of OK-432 sclerotherapy in treatment of Lymphatic<br />
Malformations: long-term follow up results<br />
Annamaria Weitz-Tuoretmaa, Leo Keski-Nisula, Riitta Rautio,<br />
Jan Valkila, Harri Keski-Säntti <strong>and</strong> Jussi Laranne<br />
15.19-16.48 Session XI (see next page)<br />
NOTES<br />
27
SCIENTIFIC PROGRAM<br />
28<br />
15.19-16.48 Session XI<br />
Chair: Gilles Soulez, Jochen Roessler<br />
15.19 Ultrasound-assisted liposuction <strong>and</strong> pull-through technique for<br />
treatment of lymphatic malformations<br />
Cameron Francis, Lily Tung, Ashley Karatsonyi, Dean Anselmo,<br />
Phillip Stanley <strong>and</strong> Andre Panossian<br />
15.27 The Difficult Airway in Patients with Vascular Anomalies of the<br />
Head <strong>and</strong> Neck: A Case Series of 238 Video Laryngoscopies using<br />
the GlideScope®<br />
Robert Bolash, Franco Resta-Flarer, Jonathan Lesser, Keith Haller,<br />
Milton Waner <strong>and</strong> Teresa O<br />
15.37 Treatment of massive tongue <strong>and</strong> cervical LMs with Sirolimus<br />
Emir Haxhija <strong>and</strong> Michael Höllwarth<br />
15.47 Clinical Follow up of Six Patients with Complicated Vascular<br />
Anomalies treated with Sirolimus<br />
Adrienne M. Hammill, Mary Sue Wentzel, Carol Chute, Manish Patel,<br />
Roshni Dasgupta, Richard G. Azizkhan <strong>and</strong> Denise M. Adams<br />
15.55 Treating Lymphatic Bone Disease: Medical Therapy in Gorham<br />
Stout Disease <strong>and</strong> Generalized Lymphatic Anomaly<br />
R Dawn Fevurly, Gulraiz Chaudry, Steven J Fishman <strong>and</strong><br />
Cameron C Trenor III<br />
16.05 Kaposiform Lymphangiomatosis: A New Entity Distinct from<br />
Generalized Lymphatic Anomaly, Kaposiform Hemangioendothelioma,<br />
Lymphedema-associated Angiosarcoma, <strong>and</strong><br />
Lymphangioma-like Kaposi Sarcoma<br />
Antonio R. Perez-Atayde, Stacy E. Croteau, Cameron C.<br />
Trenor III, Gulraiz Chaudry, Ahmad I. Alomari, John B. Mulliken,<br />
Steven J. Fishman <strong>and</strong> Harry P.W. Kozakewich<br />
16.15 Lower Extremity Lymphedema Associated with Elevated Body<br />
Mass Index in Obese Patients<br />
Arin Greene MD, MMSc, Reid Maclellan MD, Rafael Couto BA,<br />
Sumner Slavin MD <strong>and</strong> Frederick Grant MD<br />
16.23 Mutations in KIF11 cause primary lymphedema<br />
Miikka Vikkula, Antonella Mendola, Matthieu Schlögel, Arash<br />
Ghalamkarpour, Pia Ostergaard, Pradeep Vasudevan, Bart Loeys,<br />
Koen Devriendt, Thomy de Ravel, Maria Soller, Karen Fieggen,<br />
Mercedes Villanueva, Martin Bialer, Peter S. Mortimer, Sahar Mansour,<br />
Steve Jeffery, Amihood Singer, Nicole Revencu, Laurence M. Boon <strong>and</strong><br />
Pascal Brouillard<br />
16.33 Complex lymphatic venous malformation:Is there a role for<br />
rapamycin<br />
Eulalia Baselga, Manuel de Juan, Silvia Bague, Juan Carlos Pernas,<br />
Nuria Pardo, Jorge Villalba, Ana Belen Cerezuelo, Alej<strong>and</strong>ro<br />
Tomasello, Ruben Guerrero, Susana Lopez, Monica Paola Novoa,<br />
Mauricio Torres, Xavier Soria <strong>and</strong> Luis Puig<br />
SCIENTIFIC PROGRAM<br />
16.48-17.20 Sparkling refreshments in the Exhibition<br />
17.20-17.50 Closing <strong>and</strong> awards in the congress hall, at <strong>Malmö</strong> Opera<br />
19.00 ”Menu for the whole body” (Kallbadhuset)<br />
(See the map on page 10. A 30 minutes walk from the Opera)<br />
NOTES<br />
(Preregistration m<strong>and</strong>atory)<br />
29